Detalhe da pesquisa
1.
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants.
N Engl J Med
; 386(9): 837-846, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35235726
2.
Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.
N Engl J Med
; 388(16): 1533-1534, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37018470
3.
Infants Receiving a Single Dose of Nirsevimab to Prevent RSV Do Not Have Evidence of Enhanced Disease in Their Second RSV Season.
J Pediatric Infect Dis Soc
; 13(2): 144-147, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38219024
4.
Vaccine development and trials in low and lower-middle income countries: Key issues, advances and future opportunities.
Hum Vaccin Immunother
; 13(9): 2192-2199, 2017 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28758824